Cargando…
Therapeutic efficacy of polydatin for nonalcoholic fatty liver disease via regulating inflammatory response in obese mice
Polydatin (PD), a natural precursor of resveratrol, has been used to treat several diseases, such as cardiovascular diseases, hepatic diseases and various cancers. In this study, we aimed to investigate the protective effects and underlying mechanisms of PD on non-alcoholic fatty liver disease (NAFL...
Autores principales: | Mo, Juan-Fen, Wu, Jia-Yuan, Zheng, Li, Yu, Ya-Wei, Zhang, Tian-Xin, Guo, Li, Bao, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9085635/ https://www.ncbi.nlm.nih.gov/pubmed/35548751 http://dx.doi.org/10.1039/c8ra05915b |
Ejemplares similares
-
Polydatin attenuates diet-induced nonalcoholic steatohepatitis and fibrosis in mice
por: Li, Rui, et al.
Publicado: (2018) -
Compound C Protects Mice from HFD-Induced Obesity and Nonalcoholic Fatty Liver Disease
por: Wang, Fang, et al.
Publicado: (2019) -
Polydatin Inhibits Adipose Tissue Inflammation and Ameliorates Lipid Metabolism in High-Fat-Fed Mice
por: Zheng, Li, et al.
Publicado: (2019) -
Periodontitis salivary microbiota exacerbates nonalcoholic fatty liver disease in high-fat diet-induced obese mice
por: Wang, Min, et al.
Publicado: (2023) -
Photostability and antioxidant activity studies on the inclusion complexes of trans-polydatin with β-cyclodextrin and derivatives
por: Li, Shujing, et al.
Publicado: (2018)